11.71 USD
↗ 0.31 (2.72%)AT CLOSE (11:59 AM EDT)
Fennec Pharmaceuticals Inc. Common Stock
FENCNASDAQ • USD
11.72
↗ 0.00 (0.04%)
POST MARKET (AS OF 05:10 PM EDT)
Post Market
AS OF 05:10 PM EDT
11.72
↗ 0.00 (0.04%)
Market: OPEN
Fennec Pharmaceuticals Inc. Common Stock (FENC) is currently trading at $11.72. Technical and fundamental signals align bullish — technicals rate "Strong Buy" while fundamentals indicate "Buy". Notable factors include a robust Altman Z-Score, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Aug 25, 2026.
Open?$11.44
High?$11.88
Low?$11.44
Prev. Close?$11.40
Volume?198.4K
Avg. Volume?179.7K
VWAP?$11.65
Rel. Volume?1.10x
Bid / Ask
Bid?$9.37 × 100
Ask?$13.32 × 100
Spread?$3.95
Midpoint?$11.34
Valuation & Ratios
Market Cap?399.8M
Shares Out?35.1M
Float?22.4M
Float %?64.2%
P/E Ratio?N/A
P/B Ratio?9.42
EPS?-$0.09
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
Employees
35
Market Cap
399.8M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2002-01-28
Address
PO BOX 13628
RESEARCH TRIANGLE PARK, NC 27709
Phone: (919) 636-4530
RESEARCH TRIANGLE PARK, NC 27709
Phone: (919) 636-4530
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookBuy
Strong SellNeutralStrong Buy
F-Score?77
Z-Score?97
Momentum?90
Short Sent.?69
Piotroski F-Score?6/9Mixed
Altman Z-Score?4.69Safe
Confidence?71%Moderate
Short InterestLow
Short % of Float?2.37%Low
Short Interest?532.1K
Days to Cover?2.2
Free Float22.4M
Avg Daily Volume245.5K
Settlement Date2026-08-14
Financial Health
Current Ratio?5.85Strong
Quick Ratio?5.66Strong
Cash Ratio?3.33Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score58/100
P/E?N/A▾
P/B?9.42HIGH▾
Peers100
S&P20
P/S?6.75FAIR▾
Peers100
S&P18
P/FCF?N/A▾
EV/EBITDA?-318.7CHEAP▾
S&P97
EV/Sales?6.05HIGH▾
Peers100
S&P27
Returns & Efficiency
ROE?-7.7%WEAK▾
S&P10
ROA?-4.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-2040000
Enterprise Value?$358.5M
Fundamentals ratios updated end of day